Average Co-Inventor Count = 5.98
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Patent Gmbh (30 from 2,943 patents)
2. Tranzyme Pharma Inc. (5 from 19 patents)
3. Ocera Therapeutics, Inc. (2 from 26 patents)
37 patents:
1. 10836750 - TLR7/8 antagonists and uses thereof
2. 10793553 - TLR7/8 antagonists and uses thereof
3. 10517872 - Pyridazinone macrocycles as IRAK inhibitors and uses thereof
4. 10392375 - Heteroaryl compounds as IRAK inhibitors and uses thereof
5. 10287300 - Heterocyclic derivatives as modulators of kinase activity
6. 10233160 - Substituted pyrido[3,4-d]pyrimidines and pyrido[4,3-d]pyrimidines as p70S6K inhibitors
7. 10080750 - Aminopyrimidine derivatives for use as modulators of kinase activity
8. 10080753 - Heterocyclic carboxamides as modulators of kinase activity
9. 10059701 - Heteroaryl compounds as IRAK inhibitors and uses thereof
10. 9981925 - Substituted benzo[d][1,2,3]triazines as p70S6K inhibitors
11. 9969710 - Heteroaryl compounds as IRAK inhibitors and uses thereof
12. 9867826 - Heterocycles as modulators of kinase activity
13. 9850255 - Heterocyclic derivatives as modulators of kinase activity
14. 9815836 - Macrocyclic compounds as IRAK1/4 inhibitors and uses thereof
15. 9708324 - Macrocyclic compounds as IRAK1/4 inhibitors and uses thereof